Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
Eliminating hepatitis C: Still some way to go, so what needs to change?
+Practice
In print
GASTROENTEROLOGY
Eliminating hepatitis C: Still some way to go, so what needs to change?
Wednesday 28 September 2022, 12:15 AM

Hepatitis C is the leading indication for liver transplantation in New Zealand [Image: Rasi Bhadramani on iStock]
Gastroenterologist Alan Fraser says there has been exceptional progress with the diagnostic and treatment tools required to eliminate hepatitis C, but the strategies that utilise them are simply not good enough
Key points, There are excellent diagnostic tests for hepatitis C, and glecaprevir and pibrentasvir (Maviret) is a highly effective treatment; however, diagnosing , Pract Green w Pale Yellow
References
Thomas DL. Global Elimination of Chronic Hepatitis. N Engl J Med 2019;380(21):2041–50.
Howell J, Pedrana A, Cowie BC, et al. Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030. J Gastroenterol Hepatol 2019;34(1):40–48.